Revision as of 21:35, 15 October 2016

Promoter/Receptor Group Background

How does endometriosis respond to hormones?

Endometriosis is characterized by aberrant cellular responses to the ovarian hormones, estrogen and progesterone.

Estrogen Signaling Dysregulation

There are endogenous estrogen receptors in two forms: ER-alpha and ER-beta. When a healthy cell senses estrogen, the these two estrogen receptor will be activated and trigger downstream responses by binding to sequences in the genome known as estrogen responsive elements (EREs). In diseased or endometriotic cells, estrogen signaling is pathologically upregulated leading to proliferation and migration of cells outside the uterus. [1]

Progesterone Resistance

There are also endoegenous progesterone receptors in two forms: PR-A and PR-B. When a healthy cell senses progesterone, its PR receptors are activated and trigger downstream responses by binding to different sites in the genome known as progesterone responsive elements (PREs). However, in a diseased cell, while progesterone is present, it does not co-activate the progesterone receptors, and in turn does not result in any downstream effects. This disruption in the cell's normal response to progesterone is known as progesterone resistance. Research has implicated perturbations in key progesterone signaling intermediates such as HOXA10, FOX01, NFkB in causing progesterone resistance [1].

[1] http://www.nature.com/nrendo/journal/v10/n5/full/nrendo.2013.255.html

How can our circuit detect hormones?

An important aspect of synthetic biology is having inducible systems so that the output is not produced constitutively. Since progesterone is a key biomarker of endometriosis and also one of the two components of the menstural cycle. We wanted to use the sensing of progesterone as a way to inhibit our system. In contrast we wanted to use the sensing of estrogen to activate our system. Currently, there had been some research on hormone inducible promoters, but this is largely lacking in the field of synthetic biology. We decided to tackle this problem by developing our own synthetic promoter, which was based off of the key components of the commmonly used synthetic promoter, Tetracyclin Response Element promoter (TRE). We kept the basic promoter elements, but rather than having tetO responsive sites, we used progesterone and estrogen responsive elements (PRE's and ERE's respectively.

Read more about our design desicions for our inducible promoters: pERE, pPRE, and pHybrid.

Do our synthetic promoters work?

SOme text goes here ya know. Images should be from Zeiss -- ideally both mcf7 and tHESC

Read more about our experiments testing the functionality of our promoters.

@@ Line 14: / Line 14: @@
 <h1 style="color:#000000; background-color:#F20253;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS"> How does endometriosis respond to hormones?</h1>
+<p> Endometriosis is characterized by aberrant cellular responses to the ovarian hormones, estrogen and progesterone. </p>
 <img src= "https://static.igem.org/mediawiki/2016/b/b7/T--MIT--healthydiseased.png" alt = 'Hormone response diagram' style="width:250px;height:267px; float:left;"  margin: 0 1.5%; class="rotate90">
-<h2 style="text-decoration:underline; font-family: Trebuchet MS;"> Estrogen</h2>
+<h2 style="text-decoration:underline; font-family: Trebuchet MS;"> Estrogen Signaling Dysregulation</h2>
 <p style="font-family: Verdana;">There are endogenous estrogen receptors in two forms: ER-alpha and ER-beta. When a healthy cell senses estrogen, the these two estrogen receptor will be activated and trigger downstream responses by binding to sequences in the genome known as estrogen responsive elements (EREs). In diseased or endometriotic cells, estrogen signaling is pathologically upregulated leading to proliferation and migration of cells outside the uterus. [1]</p>
-<p>[1] http://www.nature.com/nrendo/journal/v10/n5/full/nrendo.2013.255.html </p>
-<h2 style="text-decoration:underline; font-family: Trebuchet MS;"> Progesterone</h2>
+<h2 style="text-decoration:underline; font-family: Trebuchet MS;"> Progesterone Resistance</h2>
-<p style="font-family:Verdana;"> There are also endoegenous progesterone receptors in two forms: PR-A and PR-B. When a healthy cell senses progesterone, its PR receptors are activated and trigger downstream responses by binding to different sites, such as a progesterone responsive element. However, in a diseased cell, while progesterone is present, it does not co-activate the progesterone receptors, and in turn does not result in any downstream effects.
+<p style="font-family:Verdana;"> There are also endoegenous progesterone receptors in two forms: PR-A and PR-B. When a healthy cell senses progesterone, its PR receptors are activated and trigger downstream responses by binding to different sites in the genome known as progesterone responsive elements <b>(PREs)</b>. However, in a diseased cell, while progesterone is present, it does not co-activate the progesterone receptors, and in turn does not result in any downstream effects. This disruption in the cell's normal response to progesterone is known as <i>progesterone resistance</i>. Research has implicated perturbations in key progesterone signaling intermediates such as HOXA10, FOX01, NFkB in causing progesterone resistance [1].
 </p>
+<p>[1] http://www.nature.com/nrendo/journal/v10/n5/full/nrendo.2013.255.html </p>
 <br></br>